<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04535921</url>
  </required_header>
  <id_info>
    <org_study_id>FCR2020</org_study_id>
    <nct_id>NCT04535921</nct_id>
  </id_info>
  <brief_title>Fear of Cancer Recurrence in Genitourinary Cancer</brief_title>
  <official_title>Fear of Cancer Recurrence in Malignant Diseases of the Genitourinary Tract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To perform an analysis of independent predictors of fear of cancer recurrence in patients&#xD;
      with malignant genitourinary diseases and their impact on quality of life and survival&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2019</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in fear of cancer recurrence pre- and postoperatively</measure>
    <time_frame>7 to 10 days after initial surgery</time_frame>
    <description>Changes in the FCR7 score pre- and postoperatively</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Fear of Cancer Recurrence</condition>
  <condition>Prostate Cancer</condition>
  <condition>Renal Cell Cancer</condition>
  <condition>Urothelial Carcinoma</condition>
  <condition>Testicle Cancer</condition>
  <arm_group>
    <arm_group_label>Prostatectomy</arm_group_label>
    <description>FCR7 questionnaire pre and postoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cystectomy</arm_group_label>
    <description>FCR7 questionnaire pre and postoperative, 6 months follow</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nephrectomy</arm_group_label>
    <description>FCR7 questionnaire pre and postoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Orchidectomy</arm_group_label>
    <description>FCR7 questionnaire pre and postoperative</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FCR7 questionnaire</intervention_name>
    <description>A 7 item questionnaire about fear of cancer recurrence</description>
    <arm_group_label>Cystectomy</arm_group_label>
    <arm_group_label>Nephrectomy</arm_group_label>
    <arm_group_label>Orchidectomy</arm_group_label>
    <arm_group_label>Prostatectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with confirmed genitourinary malignant disease undergoing curative surgical&#xD;
        treatment&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  histologically confirmed diagnosis of either prostate, urothelial cell, testicular or&#xD;
             renal cell cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ludwig-Maximilian-Universit√§t</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>80796</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yannic Volz, MD</last_name>
      <phone>089440073530</phone>
      <email>yannic.volz@med.uni-muenchen.de</email>
    </contact>
    <contact_backup>
      <last_name>Severin Rodler, MD</last_name>
      <phone>089440073530</phone>
      <email>severin.rodler@med.uni-muenchen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Yannic Volz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Severin Rodler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 27, 2020</study_first_submitted>
  <study_first_submitted_qc>September 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 2, 2020</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Yannic Volz</investigator_full_name>
    <investigator_title>Assistant doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

